# US 2022/0008665 A1 · Device For Remote Regulation and Monitoring of Drug Delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0008665 A1
- Document ID: US20220008665A1
- Status: Published application
- Kind: A1
- Application number: 17/460,212
- Filed: 2021-08-28
- Published: 2022-01-13
- Earliest claimed: 2020-06-09
- Inventors: Jacob Banov; Adam Verga; Daniel Liubovich; Brandon Kleber
- Web page: https://patentgrep.com/patent/US20220008665A1

## CPC

- A61J 7/0481: {working on a schedule basis}
- A61M 5/5086: {for indicating if defective, used, tampered with or unsterile}
- A61M 11/005: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 11/006: {operated by applying mechanical pressure to the liquid to be sprayed or atomised}
- A61M 11/007: {Syringe-type or piston-type sprayers or atomisers}
- A61M 11/02: operated by air {or other gas} pressure applied to the liquid {or other product} to be sprayed or atomised {(sprayers for horticulture A01G, A01H; killing insects A01M; air humidifying by nozzles F24F6/14, F24F6/18; cooling by spraying F28B, F28C)}
- A61M 15/0065: {Inhalators with dosage or measuring devices (A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52)}
- A61M 15/0085: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/009: {using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08)}
- A61M 15/08: Inhaling devices inserted into the nose
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 20/13: delivered from dispensers
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- A61J 2200/70: Device provided with specific sensor or indicating means
- A61J 2205/00: General identification or selection means
- A61M 15/0021: {Mouthpieces therefor}
- A61M 2016/0018: {electrical}
- A61M 2205/18: with alarm
- A61M 2205/27: preventing use
- A61M 2205/3306: Optical measuring means
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/332: Force measuring means
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/3393: by weighing the reservoir
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2205/6063: Optical identification systems
- A61M 2205/609: Biometric patient identification means
- A61M 2210/0618: Nose
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The total quantity of doses to be contained in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, collectively referred to as prescription parameters, are determined and controlled solely by a health care provider. In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose. Patient access to the medication as well as patient control of the device is limited solely to the aspects of the device necessary to administer the available dose. The device also has a monitored subassembly which detects and transmits relevant device information to a remote management system accessible to the HCP, including detected attempts to alter, access, control or otherwise tamper with the device beyond its prescribed use.

## Claims

### Claim 1

A device for use by a patient to self-administer a prescribed medication comprising:
a delivery interface, responsive to patient control actions, configured to administer a dose of the medication directly into the body of the patient;
a regulated subassembly configured to store a plurality of doses of the medication in at least one patient-inaccessible storage chamber, and for making single dose quantities of the stored medication available to said delivery interface in accordance with a prescribed dose schedule;
a monitored subassembly having at least one sensor connected to said device to detect device parameters including detected attempts to tamper with the device, and to remotely transmit said detected device parameters; and
a command subassembly configured to control said regulated subassembly in response to commands generated by a remote health care provider (HCP) and transmitted to said device.

### Claim 2 (depends on 1)

The device of claim 1, wherein said delivery interface comprises a spray nozzle.

### Claim 3 (depends on 2)

The device of claim 2, wherein said spray nozzle is configured to be inserted into a nasal passage of the patient.

### Claim 4 (depends on 1)

The device of claim 1, wherein said delivery interface comprises an inhaler.

### Claim 5 (depends on 1)

The device of claim 1, wherein said delivery interface comprises an aerosolizer.

### Claim 6 (depends on 1)

The device of claim 1, wherein said delivery interface comprises an atomizer.

### Claim 7 (depends on 6)

The device of claim 6, wherein said atomizer is a nebulizer.

### Claim 8 (depends on 7)

The device of claim 7, wherein said nebulizer is configured to deliver the medication to the lungs of the patient.

### Claim 9 (depends on 1)

The device of claim 1, wherein said delivery interface comprises a needle.

### Claim 10 (depends on 9)

The device of claim 9, wherein said needle is configured to deliver the medication via one of either intramuscular and intravenous injection.

### Claim 11

A device for use by a patient to self-administer a prescribed medication in fluid form, the device comprising:
a delivery interface, responsive to patient control actions, configured to administer a dose of the fluidic medication to the patient;
a regulated subassembly configured to store a plurality of doses of the medication in at least one patient-inaccessible storage chamber, and for making single dose quantities of the stored medication available to said delivery interface in accordance with a prescribed dose schedule;
a monitored subassembly having at least one sensor connected to said device to detect device parameters including detected attempts to tamper with the device, and to remotely transmit said detected device parameters; and
a command subassembly configured to control said regulated subassembly in response to commands generated by a remote health care provider (HCP) and transmitted to said device.

### Claim 12 (depends on 11)

The device of claim 11, wherein the fluidic medication is in the form of one of either a liquid and a gas.

### Claim 13 (depends on 12)

The device of claim 12, wherein the liquid is in the form of one of either a plurality of droplets and a stream.

### Claim 14 (depends on 11)

The device of claim 11, wherein the fluidic medication is in the form of a particle array.

### Claim 15 (depends on 11)

The device of claim 11, wherein the fluidic medication is in the form of an aerosol.

### Claim 16 (depends on 11)

The device of claim 11, wherein the fluidic medication is in the form of one of either a mist and vapor.

### Claim 17 (depends on 11)

The device of claim 11, wherein said delivery interface is configured to dispense the fluidic medication into one of either an external container and an external holding chamber.

### Claim 18

A device for use by a patient to self-administer a prescribed medication in fluid form, the device comprising:
a delivery interface, responsive to patient control actions, configured to administer a dose of the fluidic medication directly into the body of the patient;
a regulated subassembly configured to store a plurality of doses of the medication in at least one patient-inaccessible storage chamber, and for making single dose quantities of the stored medication available to said delivery interface in accordance with a prescribed dose schedule;
a monitored subassembly having at least one sensor connected to said device to detect device parameters including detected attempts to tamper with the device, and to remotely transmit said detected device parameters; and
a command subassembly configured to control said regulated subassembly in response to commands generated by a remote health care provider (HCP) and transmitted to said device.

### Claim 19 (depends on 18)

The device of claim 18, wherein said delivery interface is a nasal spray.

### Claim 20 (depends on 18)

The device of claim 18, wherein said monitored subassembly comprises a tamper sensor and an administration sensor.
